跳至主要内容
临床试验/EUCTR2013-005325-23-NL
EUCTR2013-005325-23-NL进行中(未招募)不适用

Short-term Efficacy of Stellate Ganglion Block in Men to reduce Hot Flushes related to Androgen Deprivation Therapy

Rijnstate Hospital0 个研究点开始时间: 2014年3月5日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • -General criteria;
  • Age: >18 years
  • Mean daily flush frequency of 10 or more, or mean hot flush score of 15 or higher
  • Treatment with ADT because of prostate cancer
  • Absence of any other cause of flushing
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 50
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -Use of medication that affects flushing:
  • oestrogens, progestogens, clonidine, naloxone, paroxetine, fluoxetine, venlaflaxine, gabapentin, LHRH receptor antagonist
  • -Still receiving chemotherapy of radiotherapy
  • -Psychiatric disease
  • -Any unstable concurrent disease

研究者

发起方
Rijnstate Hospital

相似试验